{
    "nct_id": "NCT03858777",
    "official_title": "Cardiomyocyte Specific Cell Free DNA as a Marker of Cardiac Sarcoidosis",
    "inclusion_criteria": "1. Sarcoidosis patients without evidence of active myocarditis:\n\n   * Inclusion:\n\n     * Diagnosis of sarcoidosis based on the ATS/ERS criteria.\n     * Normal 12 lead ECG within the past one year.\n     * Non-smoker.\n     * No immunosuppressive therapy for at least one year.\n   * Exclusion:\n\n     * Known cardiac disease.\n     * Active smoker.\n     * On immunosuppressive therapy.\n2. Sarcoidosis patients with evidence of active myocarditis:\n\n   * Inclusion:\n\n     * Diagnosis of sarcoidosis based on the ATS/ERS criteria.\n     * Evidence of active myocarditis based on recent cMRI or cFDG-PET.\n     * Non-smoker.\n   * Exclusion:\n\n     * Known cardiac disease other than sarcoidosis.\n     * Active smoker.\n     * On immunosuppressive therapy.\n3. Acute ST elevation myocardial infarction (STEMI):\n\n   * Inclusion:\n\n     * Diagnosis STEMI based on 1mm ST elevation in 2 or more contiguous leads.\n     * Symptom onset within 12 hours.\n     * Undergoing cardiac intervention for acute coronary syndrome.\n     * Able to consent for blood draw.\n   * Exclusion:\n\n     * Active smoker.\n     * Hemodynamically unstable.\n4. Healthy controls:\n\n   * Inclusion:\n\n     * No known cardiac disease.\n     * No known cardiovascular risk factors: hypertension, diabetes.\n     * Non-smoker.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}